According to Shinpoong Pharm's latest financial reports the company's current EPS (TTM) is -0,56 โฌ. In 2022 the company made an earnings per share (EPS) of -0,49 โฌ a decrease over its 2021 EPS that were of -0,17 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -0,58 โฌ | 19.59% |
2022 | -0,49 โฌ | 182.43% |
2021 | -0,17 โฌ | -326.47% |
2020 | 0,07600 โฌ | -8.85% |
2019 | 0,08338 โฌ | 75.6% |
2018 | 0,04748 โฌ | 269.67% |
2017 | 0,01284 โฌ | -103.94% |
2016 | -0,33 โฌ | -1436.05% |
2015 | 0,02442 โฌ | -71.86% |
2014 | 0,08678 โฌ | -29.56% |
2013 | 0,12 โฌ | -24.55% |
2012 | 0,16 โฌ | -68.07% |
2011 | 0,51 โฌ | 22.65% |
2010 | 0,42 โฌ | 11.53% |
2009 | 0,37 โฌ | 55.55% |
2008 | 0,24 โฌ | 19.44% |
2007 | 0,20 โฌ |